Fifteen states have now reported more than 120 cumulative cases of vaping-related lung disease or injury, according to the results of a CNN survey of state health departments.

A study published in Radiology August 20 suggests the harm of vaping tobacco products isn’t limited to nicotine itself, with users showing evidence of blood vessel damage even after smoking nicotine-free e-cigs.

“Silent” strokes are more common than overt strokes in older patients undergoing elective non-cardiac surgery, investigators with the NeuroVISION study have found.

Illinois Gov. JB Pritzker signed House Bill 3435 this month, CNN reported—a law that will require insurance companies to cover all costs of EpiPen injections for anyone under 18 years old.

Health officials in the Midwest have confirmed at least 22 cases of vaping-related lung injury this month, according to recent reports, and are in the process of investigating as many as 18 more.

Long-term exposure to ambient air pollutants—especially ozone—increase a person’s chance of developing emphysema, according to research published August 13 in JAMA.

Transport to the hospital via mobile stroke unit—as opposed to standard transit in an ambulance—saved stroke victims 10 minutes and up to 270 million neurons in a study out of the University of Texas Health Science Center at Houston.

Patients with critical limb ischemia might be better off if they opt for endovascular-first treatment over an open surgical bypass, a Circulation: Cardiovascular Quality and Outcomes study suggests.

The FDA issued an advisory August 7 updating healthcare providers and the public on its stance regarding the long-term safety of paclitaxel-coated and -eluting devices, sharing that its expert panel had indeed identified a late mortality signal associated with the devices.

TARA Biosystems’ “heart-on-a-chip” system successfully replicates human drug responses to CV medications without having to risk cardiotoxicity in human testing, researchers from TARA and GlaxoSmithKline announced August 6.

People with osteoarthritis are 23% more likely to develop CVD than their non-arthritic counterparts if they regularly use NSAIDs, according to research published in Arthritis & Rheumatology August 6.

An editorial published in The Lancet August 2 scrutinized JUUL Labs’ participation in and sponsorship of e-cigarette research in the U.S., finding the vaping giant fell short in seven of eight categories designed to test ethical integrity.